Concepts (275)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholecystectomy, Laparoscopic | 17 | 2022 | 35 | 4.190 |
Why?
|
| Cholecystitis, Acute | 7 | 2022 | 7 | 2.310 |
Why?
|
| Cholecystectomy | 8 | 2021 | 16 | 2.060 |
Why?
|
| Laparoscopy | 13 | 2022 | 145 | 1.920 |
Why?
|
| Bile Ducts | 8 | 2021 | 12 | 1.490 |
Why?
|
| Gallstones | 3 | 2022 | 6 | 1.440 |
Why?
|
| Bile Ducts, Extrahepatic | 1 | 2022 | 1 | 0.870 |
Why?
|
| Practice Guidelines as Topic | 6 | 2018 | 333 | 0.790 |
Why?
|
| Postoperative Complications | 17 | 2018 | 957 | 0.740 |
Why?
|
| Bile Duct Diseases | 4 | 2021 | 5 | 0.710 |
Why?
|
| Cholangitis | 5 | 2018 | 5 | 0.660 |
Why?
|
| General Surgery | 4 | 2014 | 49 | 0.600 |
Why?
|
| Humans | 64 | 2022 | 29337 | 0.580 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 3 | 2018 | 9 | 0.560 |
Why?
|
| Endosonography | 3 | 2017 | 11 | 0.550 |
Why?
|
| Gallbladder Diseases | 1 | 2015 | 5 | 0.550 |
Why?
|
| Severity of Illness Index | 4 | 2018 | 1113 | 0.550 |
Why?
|
| Intraoperative Complications | 4 | 2020 | 68 | 0.540 |
Why?
|
| Mesothelioma, Cystic | 1 | 2014 | 1 | 0.510 |
Why?
|
| Peritoneal Neoplasms | 1 | 2014 | 5 | 0.510 |
Why?
|
| Cysts | 3 | 2008 | 16 | 0.490 |
Why?
|
| Cholecystitis | 1 | 2013 | 7 | 0.480 |
Why?
|
| Kidney Diseases | 1 | 2014 | 115 | 0.460 |
Why?
|
| Kidney | 1 | 2014 | 173 | 0.450 |
Why?
|
| Quality Improvement | 4 | 2014 | 158 | 0.440 |
Why?
|
| Ultrasonography | 4 | 2022 | 226 | 0.420 |
Why?
|
| Male | 36 | 2018 | 15621 | 0.410 |
Why?
|
| Pancreatic Neoplasms | 6 | 2013 | 142 | 0.410 |
Why?
|
| Female | 38 | 2018 | 16197 | 0.400 |
Why?
|
| Colectomy | 3 | 2016 | 19 | 0.380 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2008 | 20 | 0.370 |
Why?
|
| Adult | 20 | 2018 | 8601 | 0.360 |
Why?
|
| Iatrogenic Disease | 2 | 2020 | 26 | 0.350 |
Why?
|
| Pancreatic Cyst | 2 | 2008 | 3 | 0.340 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2018 | 770 | 0.330 |
Why?
|
| Middle Aged | 27 | 2018 | 9823 | 0.330 |
Why?
|
| Adenocarcinoma | 6 | 2005 | 189 | 0.330 |
Why?
|
| Treatment Outcome | 12 | 2018 | 3478 | 0.320 |
Why?
|
| Multimodal Imaging | 2 | 2018 | 20 | 0.320 |
Why?
|
| Video Recording | 2 | 2018 | 47 | 0.320 |
Why?
|
| Length of Stay | 4 | 2018 | 317 | 0.290 |
Why?
|
| Endoscopy | 2 | 2021 | 181 | 0.290 |
Why?
|
| Image-Guided Biopsy | 2 | 2018 | 26 | 0.290 |
Why?
|
| Liver | 3 | 2017 | 173 | 0.290 |
Why?
|
| Retrospective Studies | 12 | 2018 | 3273 | 0.270 |
Why?
|
| Fellowships and Scholarships | 1 | 2006 | 42 | 0.270 |
Why?
|
| Surgeons | 3 | 2021 | 76 | 0.270 |
Why?
|
| Internship and Residency | 4 | 2014 | 211 | 0.270 |
Why?
|
| Aged | 22 | 2018 | 9448 | 0.270 |
Why?
|
| United States | 9 | 2021 | 2333 | 0.250 |
Why?
|
| Drainage | 4 | 2017 | 50 | 0.250 |
Why?
|
| Colonic Neoplasms | 2 | 2016 | 66 | 0.250 |
Why?
|
| Biopsy | 2 | 2014 | 234 | 0.250 |
Why?
|
| Tokyo | 6 | 2018 | 6 | 0.240 |
Why?
|
| Surveys and Questionnaires | 4 | 2021 | 1184 | 0.210 |
Why?
|
| Stomach Neoplasms | 4 | 2015 | 30 | 0.200 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 1991 | 90 | 0.190 |
Why?
|
| Blood Loss, Surgical | 2 | 2018 | 64 | 0.190 |
Why?
|
| Aged, 80 and over | 7 | 2018 | 4851 | 0.190 |
Why?
|
| Prospective Studies | 7 | 2018 | 1811 | 0.190 |
Why?
|
| Operative Time | 2 | 2018 | 80 | 0.190 |
Why?
|
| Education, Medical, Graduate | 2 | 2014 | 79 | 0.190 |
Why?
|
| Societies, Medical | 1 | 2021 | 190 | 0.190 |
Why?
|
| Hernia, Ventral | 2 | 2014 | 17 | 0.180 |
Why?
|
| Surgical Mesh | 2 | 2014 | 22 | 0.180 |
Why?
|
| Disease Management | 2 | 2017 | 114 | 0.180 |
Why?
|
| Stents | 2 | 2017 | 76 | 0.180 |
Why?
|
| Diagnosis, Differential | 3 | 2014 | 389 | 0.180 |
Why?
|
| Safety | 2 | 2016 | 45 | 0.180 |
Why?
|
| Hernia, Inguinal | 2 | 1996 | 16 | 0.170 |
Why?
|
| Carcinoma | 2 | 2016 | 57 | 0.160 |
Why?
|
| Cholelithiasis | 3 | 1995 | 10 | 0.160 |
Why?
|
| Patient Admission | 1 | 2018 | 27 | 0.160 |
Why?
|
| Immunohistochemistry | 3 | 2018 | 391 | 0.160 |
Why?
|
| Survival Rate | 6 | 2018 | 349 | 0.160 |
Why?
|
| Herniorrhaphy | 2 | 2014 | 27 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 2 | 2018 | 402 | 0.160 |
Why?
|
| Lymph Nodes | 1 | 2018 | 70 | 0.160 |
Why?
|
| Hypertrophy | 1 | 2017 | 19 | 0.160 |
Why?
|
| Checklist | 1 | 2017 | 36 | 0.160 |
Why?
|
| Neovascularization, Physiologic | 1 | 2017 | 22 | 0.160 |
Why?
|
| Biliary Tract Diseases | 2 | 1994 | 4 | 0.150 |
Why?
|
| Liver Regeneration | 1 | 2017 | 24 | 0.150 |
Why?
|
| Acute Disease | 4 | 2018 | 226 | 0.150 |
Why?
|
| Follow-Up Studies | 7 | 2014 | 1830 | 0.150 |
Why?
|
| Diagnostic Imaging | 1 | 2017 | 90 | 0.150 |
Why?
|
| Portal Vein | 1 | 2017 | 40 | 0.150 |
Why?
|
| Professional Practice | 1 | 1996 | 10 | 0.140 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2016 | 6 | 0.140 |
Why?
|
| Enterostomy | 1 | 2016 | 5 | 0.140 |
Why?
|
| Gastrectomy | 2 | 2015 | 24 | 0.140 |
Why?
|
| Hypertension, Portal | 1 | 1995 | 1 | 0.140 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 46 | 0.140 |
Why?
|
| Ascites | 1 | 1995 | 5 | 0.140 |
Why?
|
| Blood Coagulation Disorders | 1 | 1995 | 14 | 0.130 |
Why?
|
| Algorithms | 1 | 2018 | 400 | 0.130 |
Why?
|
| Intensive Care Units | 1 | 2018 | 301 | 0.130 |
Why?
|
| Clinical Competence | 2 | 2014 | 230 | 0.130 |
Why?
|
| Hospital Costs | 1 | 1996 | 68 | 0.130 |
Why?
|
| Cholangiography | 5 | 2015 | 11 | 0.130 |
Why?
|
| Abdominal Neoplasms | 1 | 2014 | 9 | 0.130 |
Why?
|
| Appendectomy | 1 | 2014 | 15 | 0.130 |
Why?
|
| Problem-Based Learning | 1 | 2014 | 8 | 0.130 |
Why?
|
| Appendicitis | 1 | 2014 | 18 | 0.130 |
Why?
|
| Biliary Fistula | 2 | 2014 | 5 | 0.130 |
Why?
|
| Congenital Abnormalities | 1 | 2014 | 7 | 0.130 |
Why?
|
| Liver Diseases | 1 | 1995 | 41 | 0.130 |
Why?
|
| Pancreaticoduodenectomy | 2 | 2013 | 27 | 0.130 |
Why?
|
| Hernia, Hiatal | 1 | 2014 | 11 | 0.130 |
Why?
|
| Palliative Care | 1 | 1996 | 145 | 0.130 |
Why?
|
| Models, Educational | 1 | 2014 | 36 | 0.130 |
Why?
|
| Lymphoma | 1 | 2014 | 44 | 0.130 |
Why?
|
| Abdominal Pain | 2 | 1991 | 9 | 0.130 |
Why?
|
| Risk Assessment | 3 | 2018 | 679 | 0.130 |
Why?
|
| Intestine, Small | 2 | 2014 | 33 | 0.130 |
Why?
|
| Duodenal Neoplasms | 2 | 2013 | 7 | 0.130 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2015 | 132 | 0.120 |
Why?
|
| Gastrointestinal Diseases | 2 | 1995 | 43 | 0.120 |
Why?
|
| Hemobilia | 1 | 2014 | 1 | 0.120 |
Why?
|
| Respiratory Tract Fistula | 1 | 2014 | 1 | 0.120 |
Why?
|
| Mirizzi Syndrome | 1 | 2014 | 1 | 0.120 |
Why?
|
| Cutaneous Fistula | 1 | 2014 | 3 | 0.120 |
Why?
|
| Ileus | 1 | 2014 | 3 | 0.120 |
Why?
|
| Urinary Fistula | 1 | 2014 | 3 | 0.120 |
Why?
|
| Duodenal Diseases | 1 | 2014 | 6 | 0.120 |
Why?
|
| Vascular Fistula | 1 | 2014 | 4 | 0.120 |
Why?
|
| Intestinal Fistula | 1 | 2014 | 7 | 0.120 |
Why?
|
| Credentialing | 1 | 2014 | 8 | 0.120 |
Why?
|
| Elective Surgical Procedures | 1 | 2014 | 43 | 0.120 |
Why?
|
| Prognosis | 7 | 2018 | 840 | 0.120 |
Why?
|
| Biomarkers, Tumor | 1 | 2014 | 175 | 0.110 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2013 | 31 | 0.110 |
Why?
|
| Biliary Tract Neoplasms | 2 | 1991 | 3 | 0.110 |
Why?
|
| Lithotripsy | 1 | 1992 | 1 | 0.110 |
Why?
|
| Sepsis | 1 | 2014 | 144 | 0.110 |
Why?
|
| Physicians | 1 | 2014 | 115 | 0.110 |
Why?
|
| Young Adult | 1 | 2018 | 1932 | 0.100 |
Why?
|
| Appendiceal Neoplasms | 1 | 1991 | 3 | 0.100 |
Why?
|
| Sarcoma, Kaposi | 1 | 1991 | 4 | 0.100 |
Why?
|
| Opportunistic Infections | 1 | 1990 | 8 | 0.100 |
Why?
|
| Risk Factors | 4 | 2020 | 2443 | 0.090 |
Why?
|
| Logistic Models | 3 | 2016 | 407 | 0.090 |
Why?
|
| Recurrence | 3 | 2014 | 350 | 0.090 |
Why?
|
| Databases, Factual | 3 | 2016 | 330 | 0.090 |
Why?
|
| History, 19th Century | 1 | 2007 | 66 | 0.080 |
Why?
|
| History, 20th Century | 1 | 2007 | 84 | 0.080 |
Why?
|
| Pancreatectomy | 2 | 2003 | 10 | 0.080 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2014 | 300 | 0.080 |
Why?
|
| Monitoring, Intraoperative | 1 | 2007 | 37 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1988 | 178 | 0.070 |
Why?
|
| Registries | 1 | 2007 | 188 | 0.070 |
Why?
|
| Carcinosarcoma | 1 | 2005 | 4 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 553 | 0.070 |
Why?
|
| Pancreas | 1 | 2005 | 32 | 0.070 |
Why?
|
| Contraindications | 2 | 1995 | 41 | 0.070 |
Why?
|
| Sphincter of Oddi | 1 | 1984 | 1 | 0.060 |
Why?
|
| Liver Neoplasms | 2 | 1997 | 103 | 0.060 |
Why?
|
| Ampulla of Vater | 1 | 1984 | 6 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2018 | 1221 | 0.060 |
Why?
|
| Morbidity | 2 | 2014 | 63 | 0.060 |
Why?
|
| Intraoperative Period | 3 | 1997 | 29 | 0.060 |
Why?
|
| Polypropylenes | 1 | 2003 | 2 | 0.060 |
Why?
|
| Polytetrafluoroethylene | 1 | 2003 | 5 | 0.060 |
Why?
|
| Survival Analysis | 3 | 2015 | 298 | 0.050 |
Why?
|
| Duodenum | 2 | 1994 | 12 | 0.050 |
Why?
|
| Hepatectomy | 2 | 2017 | 55 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2008 | 788 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 1992 | 364 | 0.040 |
Why?
|
| Anastomosis, Surgical | 2 | 2016 | 34 | 0.040 |
Why?
|
| Biliary Tract Surgical Procedures | 1 | 2018 | 2 | 0.040 |
Why?
|
| Software Design | 1 | 2017 | 1 | 0.040 |
Why?
|
| Conversion to Open Surgery | 1 | 2017 | 3 | 0.040 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2018 | 9 | 0.040 |
Why?
|
| Ultrasonography, Doppler | 1 | 2018 | 15 | 0.040 |
Why?
|
| Gallbladder | 1 | 2017 | 5 | 0.040 |
Why?
|
| Japan | 1 | 2017 | 12 | 0.040 |
Why?
|
| Korea | 1 | 2017 | 10 | 0.040 |
Why?
|
| Taiwan | 1 | 2017 | 7 | 0.040 |
Why?
|
| Conservative Treatment | 1 | 2017 | 13 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 36 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2017 | 27 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2018 | 65 | 0.040 |
Why?
|
| Liver Circulation | 1 | 2017 | 3 | 0.040 |
Why?
|
| Portal Pressure | 1 | 2017 | 3 | 0.040 |
Why?
|
| Ligation | 1 | 2017 | 32 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2018 | 101 | 0.040 |
Why?
|
| Swine | 1 | 2017 | 80 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2018 | 227 | 0.040 |
Why?
|
| Organ Size | 1 | 2017 | 107 | 0.040 |
Why?
|
| Community-Acquired Infections | 1 | 2018 | 78 | 0.040 |
Why?
|
| Laparotomy | 2 | 1997 | 21 | 0.040 |
Why?
|
| Random Allocation | 1 | 2017 | 146 | 0.040 |
Why?
|
| Consensus | 1 | 2017 | 105 | 0.040 |
Why?
|
| Patient Safety | 1 | 2017 | 51 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2015 | 1939 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2018 | 394 | 0.040 |
Why?
|
| Gastrostomy | 1 | 1996 | 8 | 0.040 |
Why?
|
| Jejunostomy | 1 | 1996 | 6 | 0.040 |
Why?
|
| Cost Savings | 1 | 1996 | 36 | 0.030 |
Why?
|
| Prothrombin Time | 1 | 1995 | 2 | 0.030 |
Why?
|
| Whole Blood Coagulation Time | 1 | 1995 | 4 | 0.030 |
Why?
|
| Platelet Count | 1 | 1995 | 20 | 0.030 |
Why?
|
| Hemostasis, Surgical | 1 | 1995 | 15 | 0.030 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1995 | 14 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 1996 | 144 | 0.030 |
Why?
|
| Neuroendocrine Tumors | 1 | 1995 | 17 | 0.030 |
Why?
|
| Intestines | 1 | 2016 | 107 | 0.030 |
Why?
|
| Thrombocytopenia | 1 | 1995 | 30 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2017 | 502 | 0.030 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 1996 | 74 | 0.030 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 1994 | 3 | 0.030 |
Why?
|
| Competitive Behavior | 1 | 2014 | 7 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2015 | 63 | 0.030 |
Why?
|
| Punctures | 1 | 1994 | 10 | 0.030 |
Why?
|
| Abdominal Injuries | 1 | 1994 | 4 | 0.030 |
Why?
|
| Hemoglobins | 1 | 1995 | 81 | 0.030 |
Why?
|
| Colonic Diseases | 1 | 2014 | 12 | 0.030 |
Why?
|
| Stomach | 1 | 1994 | 18 | 0.030 |
Why?
|
| Illinois | 1 | 2014 | 241 | 0.030 |
Why?
|
| Cholestasis | 1 | 1993 | 8 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 87 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2014 | 64 | 0.030 |
Why?
|
| Digestive System | 1 | 1993 | 16 | 0.030 |
Why?
|
| Time Factors | 2 | 2014 | 1616 | 0.030 |
Why?
|
| Wound Healing | 1 | 2014 | 168 | 0.030 |
Why?
|
| Animals | 2 | 2017 | 4552 | 0.030 |
Why?
|
| Puerto Rico | 1 | 1993 | 12 | 0.030 |
Why?
|
| Nervous System Neoplasms | 1 | 1992 | 3 | 0.030 |
Why?
|
| Endocrine Gland Neoplasms | 1 | 1992 | 2 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 2014 | 97 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 1993 | 44 | 0.030 |
Why?
|
| Ursodeoxycholic Acid | 1 | 1992 | 2 | 0.030 |
Why?
|
| Data Collection | 1 | 1993 | 107 | 0.030 |
Why?
|
| Colic | 1 | 1992 | 2 | 0.030 |
Why?
|
| Neurosecretory Systems | 1 | 1991 | 9 | 0.030 |
Why?
|
| Incidence | 1 | 1994 | 756 | 0.030 |
Why?
|
| Emergencies | 1 | 1990 | 39 | 0.020 |
Why?
|
| Intestinal Obstruction | 1 | 1987 | 12 | 0.020 |
Why?
|
| Bile Duct Neoplasms | 1 | 1986 | 12 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 521 | 0.020 |
Why?
|
| Reoperation | 2 | 1993 | 932 | 0.020 |
Why?
|
| Common Bile Duct | 1 | 1986 | 2 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1988 | 290 | 0.020 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 1986 | 7 | 0.020 |
Why?
|
| Angiography | 1 | 1986 | 38 | 0.020 |
Why?
|
| Common Bile Duct Diseases | 1 | 1984 | 2 | 0.020 |
Why?
|
| Dogs | 1 | 1984 | 253 | 0.010 |
Why?
|
| Ganglioneuroma | 1 | 2003 | 4 | 0.010 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 2003 | 4 | 0.010 |
Why?
|
| Peritoneum | 1 | 2003 | 18 | 0.010 |
Why?
|
| Pancreatitis | 1 | 2003 | 22 | 0.010 |
Why?
|
| Ethanol | 1 | 1984 | 134 | 0.010 |
Why?
|
| Biomechanical Phenomena | 1 | 1984 | 668 | 0.010 |
Why?
|
| Radiography | 2 | 1994 | 678 | 0.010 |
Why?
|
| Age Factors | 2 | 1997 | 843 | 0.010 |
Why?
|
| Adolescent | 1 | 1986 | 2279 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 1999 | 324 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 1997 | 82 | 0.010 |
Why?
|
| Sex Factors | 1 | 1997 | 496 | 0.010 |
Why?
|
| Peptic Ulcer | 1 | 1994 | 6 | 0.010 |
Why?
|
| Digestive System Neoplasms | 1 | 1993 | 5 | 0.010 |
Why?
|
| Larynx | 1 | 1993 | 16 | 0.010 |
Why?
|
| Leiomyosarcoma | 1 | 1993 | 7 | 0.010 |
Why?
|
| Gastroplasty | 1 | 1994 | 21 | 0.010 |
Why?
|
| Pharynx | 1 | 1993 | 14 | 0.010 |
Why?
|
| Esophagus | 1 | 1993 | 59 | 0.010 |
Why?
|
| Contrast Media | 1 | 1994 | 125 | 0.010 |
Why?
|
| Gastric Bypass | 1 | 1994 | 52 | 0.010 |
Why?
|
| Immunologic Techniques | 1 | 1991 | 3 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1991 | 22 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 1992 | 340 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 1991 | 146 | 0.010 |
Why?
|
| Pancreatic Fistula | 1 | 1986 | 2 | 0.000 |
Why?
|
| Gastric Emptying | 1 | 1986 | 13 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1986 | 56 | 0.000 |
Why?
|